M. D. de Maat

发表

A case-only approach for assessing gene by sex interaction in human longevity.

A. Yashin, J. Vaupel, K. Christensen, 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus

C. Kluft, A. Meinders, H. Princen, 2003, Journal of thrombosis and haemostasis : JTH.

Anti-Atherosclerotic Effect of Amlodipine, Alone and in Combination With Atorvastatin, in APOE*3-Leiden/hCRP Transgenic Mice

L. Havekes, A. Szalai, H. Princen, 2006, Journal of Cardiovascular Pharmacology.

The long‐term within‐ and between‐laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation

C. Kluft, F. Haverkate, P. Meijer, 2003, Journal of thrombosis and haemostasis : JTH.

Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo

V. V. van Hinsbergh, P. Koolwijk, E. Kaijzel, 2006, Journal of thrombosis and haemostasis : JTH.

Genetic influence on thrombotic risk markers in the elderly – a Danish twin study

K. Christensen, J. Hjelmborg, J. Hjelmborg, 2006, Journal of thrombosis and haemostasis : JTH.

Logistics and quality control for DNA sampling in large multicenter studies

M L Simoons, M. Simoons, C. Kluft, 2003, Journal of thrombosis and haemostasis : JTH.

Longevity Is Independent of Common Variations in Genes Associated with Cardiovascular Risk

S. Kristensen, J. Jespersen, M. D. de Maat, 1999, Thrombosis and Haemostasis.

No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice

J. Jukema, M. Maas, A. Van der Laarse, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.

Robert Kleemann, Lars Verschuren, Teake Kooistra, 2004, Blood.

Is Quantitative Determination of Fibrin(ogen) Degradation Products and Thrombin-Antithrombin III Complexes Useful to Diagnose Deep Venous Thrombosis in Outpatients?

M. D. de Maat, P. V. van Bergen, A. D. de Boer, 1989, Thrombosis and Haemostasis.

Effects of Gemfibrozil and Ciprofibrate on Plasma Levels of Tissue-type Plasminogen Activator, Plasminogen Activator Inhibitor-1 and Fibrinogen in Hyperlipidaemic Patients

J. Kastelein, T. Kooistra, C. Kluft, 1997, Thrombosis and Haemostasis.

Effect of Strenuous Exercise on Fibrinogen and Fibrinolysis in Healthy Elderly Men and Women

A. Schuit, E. Schouten, F. Kok, 1997, Thrombosis and Haemostasis.

Modulation of Plasma Fibrinogen Levels by Ticlopidine in Healthy Volunteers and Patients with Stable Angina Pectoris

S. van Buuren, S. Buuren, J. Wilson, 1996, Thrombosis and Haemostasis.

Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.

M. Simoons, M. D. de Maat, A. Danser, 2014, Clinical science.

DNA-Polymorphisms and Plasma Levels of Vascular Disease Risk Factors in Greenland Inuit

P. de Knijff, J. Jespersen, C. Kluft, 1999, Thrombosis and Haemostasis.

Inflammation, thrombosis and atherosclerosis: results of the Glostrup study

K. Borch-Johnsen, J. Jespersen, T. Drivsholm, 2003, Journal of thrombosis and haemostasis : JTH.

The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor

J. T. ten Berg, F. Leebeek, A. Kruit, 2009, Thrombosis and Haemostasis.

Coagulation biomarkers for ischemic stroke

H. ten Cate, M. D. de Maat, A. G. Jansen, 2023, Research and practice in thrombosis and haemostasis.

An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values

J. Weisel, M. D. de Maat, M. Pieters, 2012, Journal of thrombosis and haemostasis : JTH.

Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome

P. Serruys, H. Garcia-Garcia, E. Boersma, 2015, Thrombosis and Haemostasis.

Coagulation Factor VII, Serum-Triglycerides and the R/Q353 Polymorphism: Differences between Older Men and Women

A. Hofman, D. Grobbee, E. Schouten, 1997, Thrombosis and Haemostasis.

Association between Polymorphisms in the Fibrinogen α- and β-Genes on the Post-trauma Fibrinogen Increase

M. D. de Maat, M. P. Maat, J. Pimentel, 1998 .

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.

A. Uitterlinden, J. Witteman, A. Isaacs, 2010, European heart journal.

Anticoagulant Effect of Dietary Fish Oil in Hyperlipidemia: A Study of Hepatic Gene Expression in APOE2 Knock-in Mice

M. Hofker, J. Heemskerk, P. J. V. van Gorp, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.

H. V. van Buuren, W. Nieuwenhuizen, M. D. de Maat, 1995, Thrombosis research.